Semen clusterin is a novel DC-SIGN ligand

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5299-5309

  Sabatte, Juan ^a,b   Faigle, Wolfgang ^c   Ceballos, Ana ^a   Morelle, Willy ^d   Rodríguez Rodrígues, Christian ^b   Remes Lenicov, Federico ^b   Thépaut, Michel ^e   Fieschi, Franck ^e   Malchiodi, Emilio ^f   Fernández, Marisa ^f   Arenzana Seisdedos, Fernando ^b   Lortat Jacob, Hugues ^e   Michalski, Jean Claude ^d   Geffner, Jorge ^a,b   Amigorena, Sebastian ^a  

^a INSERM   (France)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUT CURIE   (France)

^d UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^e CEA GRENOBLE   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD209 ANTIGEN; CLUSTERIN; FUCOSE; GLYCAN; LIGAND; SEMEN CLUSTERIN; SERUM CLUSTERIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INFLAMMATION; NEOPLASM; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; SEXUALLY TRANSMITTED DISEASE; SPERM;

ADULT; ANTIVIRAL AGENTS; CELL ADHESION MOLECULES; CLUSTERIN; DENDRITIC CELLS; FUCOSE; GLYCOSYLATION; HIV-1; HUMANS; LECTINS, C-TYPE; LIGANDS; MALE; MANNOSE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SEMEN;

EID: 81455141910     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101889     Document Type: Article

References (61)

1. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667. (Pubitemid 34293436)
2. Geijtenbeek, T. B., S. J. van Vliet, A. Engering, B. A. 't Hart, and Y. van Kooyk. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22: 33-54. (Pubitemid 38680417)
3. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21: 317-337.
4. van Kooyk, Y. 2008. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem. Soc. Trans. 36: 1478-1481.
5. Gringhuis, S. I., J. den Dunnen, M. Litjens, M. van der Vlist, and T. B. Geijtenbeek. 2009. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10: 1081-1088.
6. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709.
7. Guo, Y., H. Feinberg, E. Conroy, D. A. Mitchell, R. Alvarez, O. Blixt, M. E. Taylor, W. I. Weis, and K. Drickamer. 2004. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11: 591-598. (Pubitemid 38823524)
8. Svajger, U., M. Anderluh, M. Jeras, and N. Obermajer. 2010. C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal 22: 1397-1405.
9. Sabatté, J., A. Ceballos, S. Raiden, M. Vermeulen, K. Nahmod, J. Maggini, G. Salamone, H. Salomón, S. Amigorena, and J. Geffner. 2007. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J. Virol. 81: 13723-13734. (Pubitemid 350247865)
10. Kim, K. A., M. Yolamanova, O. Zirafi, N. R. Roan, L. Staendker, W. G. Forssmann, A. Burgener, N. Dejucq-Rainsford, B. H. Hahn, G. M. Shaw, et al. 2010. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7: 55.
11. Stax, M. J., T. van Montfort, R. R. Sprenger, M. Melchers, R. W. Sanders, E. van Leeuwen, S. Repping, G. Pollakis, D. Speijer, and W. A. Paxton. 2009. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes. Virology 391: 203-211.
12. Holtzman, D. M. 2004. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23: 247-254.
13. Jones, S. E., and C. Jomary. 2002. Clusterin. Int. J. Biochem. Cell Biol. 34: 427-431. (Pubitemid 34242756)
14. Rizzi, F., and S. Bettuzzi. 2008. Targeting Clusterin in prostate cancer. J. Physiol. Pharmacol. 59(Suppl 9): 265-274.
15. Trougakos, I. P., J. Y. Djeu, E. S. Gonos, and D. A. Boothman. 2009. Advances and challenges in basic and translational research on clusterin. Cancer Res. 69: 403-406.
16. Zhang, H., J. K. Kim, C. A. Edwards, Z. Xu, R. Taichman, and C. Y. Wang. 2005. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7: 909-915. (Pubitemid 41486292)
17. Wilson, M. R., and S. B. Easterbrook-Smith. 2000. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25: 95-98. (Pubitemid 30122416)
18. Bettuzzi, S. 2009. Conclusions and perspectives. Adv. Cancer Res. 105: 133-150.
19. Falgarone, G., and G. Chiocchia. 2009. Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv. Cancer Res. 104: 139-170.
20. Klock, G., M. Baiersdörfer, and C. Koch-Brandt. 2009. Chapter 7: Cell protective functions of secretory Clusterin (sCLU). Adv. Cancer Res. 104: 115-138.
21. Wyatt, A., J. Yerbury, S. Poon, R. Dabbs, and M. Wilson. 2009. Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding. Adv. Cancer Res. 104: 89-114.
22. Choi, N. H., T. Tobe, K. Hara, H. Yoshida, and M. Tomita. 1990. Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum. J. Immunol. Methods 131: 159-163. (Pubitemid 20241515)
23. O'Bryan, M. K., H. W. Baker, J. R. Saunders, L. Kirszbaum, I. D. Walker, P. Hudson, D. Y. Liu, M. D. Glew, A. J. d'Apice, and B. F. Murphy. 1990. Human seminal clusterin (SP-40,40). Isolation and characterization. J. Clin. Invest. 85: 1477-1486. (Pubitemid 20176441)
24. Tenniswood, M., Z. Wang, J. Lakins, C. Morrissey, J. O'Sullivan, and H. Tang. 1998. Clusterin in the male reproductive tract. J. Androl. 19: 508-516.
25. Ceballos, A., F. Remes Lenicov, J. Sabatte, C. Rodriguez Rodrigues, M. Cabrini, C. Jancic, S. Raiden, M. Donaldson, R. Agustin Pasqualini, Jr., C. Marin- Briggiler, et al. 2009. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J. Exp. Med. 206: 2717-2733.
26. Tabarani, G., M. Thépaut, D. Stroebel, C. Ebel, C. Vivès, P. Vachette, D. Durand, and F. Fieschi. 2009. DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J. Biol. Chem. 284: 21229-21240.
27. Morelle, W., V. Faid, F. Chirat, and J. C. Michalski. 2009. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry. Methods Mol. Biol. 534: 5-21.
28. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
29. Kapron, J. T., G. M. Hilliard, J. N. Lakins, M. P. Tenniswood, K. A. West, S. A. Carr, and J. W. Crabb. 1997. Identification and characterization of glycosylation sites in human serum clusterin. Protein Sci. 6: 2120-2133. (Pubitemid 27449292)
30. Morelle, W., and J. C. Michalski. 2007. Analysis of protein glycosylation by mass spectrometry. Nat. Protoc. 2: 1585-1602. (Pubitemid 47028845)
31. Jenne, D. E., B. Lowin, M. C. Peitsch, A. Böttcher, G. Schmitz, and J. Tschopp. 1991. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J. Biol. Chem. 266: 11030-11036. (Pubitemid 21906907)
32. Humphreys, D. T., J. A. Carver, S. B. Easterbrook-Smith, and M. R. Wilson. 1999. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J. Biol. Chem. 274: 6875-6881.
33. Poon, S., T. M. Treweek, M. R. Wilson, S. B. Easterbrook-Smith, and J. A. Carver. 2002. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett. 513: 259-266. (Pubitemid 34251275)
34. Wyatt, A. R., J. J. Yerbury, and M. R. Wilson. 2009. Structural characterization of clusterin-chaperone client protein complexes. J. Biol. Chem. 284: 21920-21927.
35. Wyatt, A. R., and M. R. Wilson. 2010. Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J. Biol. Chem. 285: 3532-3539.
36. Schwartz, A. J., X. Alvarez, and A. A. Lackner. 2002. Distribution and immunophenotype of DC-SIGN-expressing cells in SIV-infected and uninfected macaques. AIDS Res. Hum. Retroviruses 18: 1021-1029.
37. Jameson, B., F. Baribaud, S. Pöhlmann, D. Ghavimi, F. Mortari, R. W. Doms, and A. Iwasaki. 2002. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76: 1866-1875. (Pubitemid 34094633)
38. Jones, J. S., L. Rossman, M. Hartman, and C. C. Alexander. 2003. Anogenital injuries in adolescents after consensual sexual intercourse. Acad. Emerg. Med. 10: 1378-1383. (Pubitemid 37531860)
39. Norvell, M. K., G. I. Benrubi, and R. J. Thompson. 1984. Investigation of microtrauma after sexual intercourse. J. Reprod. Med. 29: 269-271. (Pubitemid 14138877)
40. Galvin, S. R., and M. S. Cohen. 2004. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2: 33-42. (Pubitemid 39490046)
41. Piot, P., and M. Laga. 1989. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. BMJ 298: 623-624.
42. Serwadda, D., R. H. Gray, N. K. Sewankambo, F. Wabwire-Mangen, M. Z. Chen, T. C. Quinn, T. Lutalo, N. Kiwanuka, G. Kigozi, F. Nalugoda, et al. 2003. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J. Infect. Dis. 188: 1492-1497. (Pubitemid 37523934)
43. Chieppa, M., M. Rescigno, A. Y. Huang, and R. N. Germain. 2006. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203: 2841-2852. (Pubitemid 46026162)
44. Shattock, R. J., and J. P. Moore. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1: 25-34.
45. Politch, J. A., L. Tucker, F. P. Bowman, and D. J. Anderson. 2007. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 22: 2928-2935. (Pubitemid 351696814)
46. Robertson, S. A., L. R. Guerin, J. J. Bromfield, K. M. Branson, A. C. Ahlström, and A. S. Care. 2009. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 80: 1036-1045.
47. Badia, R., A. Iborra, J. R. Palacio, M. Antich, and P. Martínez. 2008. The effect of oxidative environment on immunosuppressive properties of human seminal plasma. Am. J. Reprod. Immunol. 60: 354-360.
48. Guerin, L. R., J. R. Prins, and S. A. Robertson. 2009. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update 15: 517-535.
49. Kelly, R. W., and H. O. Critchley. 1997. Immunomodulation by human seminal plasma: a benefit for spermatozoon and pathogen? Hum. Reprod. 12: 2200-2207.
50. Robertson, S. A., W. V. Ingman, S. O'Leary, D. J. Sharkey, and K. P. Tremellen. 2002. Transforming growth factor beta - a mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 57: 109-128. (Pubitemid 35245743)
51. Robertson, S. A., and D. J. Sharkey. 2001. The role of semen in induction of maternal immune tolerance to pregnancy. Semin. Immunol. 13: 243-254. (Pubitemid 32666204)
52. Svajger, U., N. Obermajer, M. Anderluh, J. Kos, and M. Jeras. 2011. DC-SIGN ligation greatly affects dendritic cell differentiation from monocytes compromising their normal function. J. Leukoc. Biol. 89: 893-905.
53. Shannan, B., M. Seifert, K. Leskov, J. Willis, D. Boothman, W. Tilgen, and J. Reichrath. 2006. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13: 12-19.
54. Dube, D. H., and C. R. Bertozzi. 2005. Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4: 477-488. (Pubitemid 40861990)
55. Hakomori, S. 2002. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99: 10231-10233.
56. van Kooyk, Y., and G. A. Rabinovich. 2008. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9: 593-601. (Pubitemid 351712630)
57. Aarnoudse, C. A., J. J. Garcia Vallejo, E. Saeland, and Y. van Kooyk. 2006. Recognition of tumor glycans by antigen-presenting cells. Curr. Opin. Immunol. 18: 105-111. (Pubitemid 43049656)
58. Nonaka, M., B. Y. Ma, H. Imaeda, K. Kawabe, N. Kawasaki, K. Hodohara, N. Kawasaki, A. Andoh, Y. Fujiyama, and T. Kawasaki. 2011. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J. Biol. Chem. 286: 22403-22413.
59. Nonaka, M., B. Y. Ma, R. Murai, N. Nakamura, M. Baba, N. Kawasaki, K. Hodohara, S. Asano, and T. Kawasaki. 2008. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J. Immunol. 180: 3347-3356.
60. Saeland, E., S. J. van Vliet, M. Bäckström, V. C. van den Berg, T. B. Geijtenbeek, G. A. Meijer, and Y. van Kooyk. 2007. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol. Immunother. 56: 1225-1236. (Pubitemid 46763937)
61. van Gisbergen, K. P., C. A. Aarnoudse, G. A. Meijer, T. B. Geijtenbeek, and Y. van Kooyk. 2005. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 65: 5935-5944.